ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $139M (100.0% shares, 0.0% debt)

Holdings (31)

— KADMON HLDGS INC 11.7%

Value $16.16M Shares 6,412,500 Est. Cost $3.68 Unrealized —

IOVA IOVANCE BIOTHERAPEUTICS INC 9.6%

Value $13.24M Shares 727,500 Est. Cost $7.92 Unrealized +179.3%

ARVN ARVINAS INC 8.8%

Value $12.21M Shares 566,500 Est. Cost $19.30 Unrealized +27.2%

XBI SPDR SERIES TRUST 8.3%

Value $11.44M Shares 150,000 Est. Cost — Unrealized —

ARWR ARROWHEAD PHARMACEUTICALS IN 7.9%

Value $10.92M Shares 387,500 Est. Cost $20.04 Unrealized +47.7%

AXSM AXSOME THERAPEUTICS INC 7.6%

Value $10.57M Shares 522,500 Est. Cost $20.96 Unrealized +22.6%

MIST MILESTONE PHARMACEUTICALS IN 5.0%

Value $6.891M Shares 369,500 Est. Cost $20.57 Unrealized -4.2%

XENE XENON PHARMACEUTICALS INC 4.6%

Value $6.33M Shares 702,500 Est. Cost $7.43 Unrealized +27.2%

CRSP CRISPR THERAPEUTICS AG 4.0%

Value $5.493M Shares 134,000 Est. Cost $43.18 Unrealized +10.7%

PTGX PROTAGONIST THERAPEUTICS INC 3.6%

Value $5.026M Shares 418,500 Est. Cost $9.94 Unrealized +26.9%

— BELLUS HEALTH INC NEW 3.6%

Value $5.016M Shares 785,000 Est. Cost $6.39 Unrealized —

AUPH AURINIA PHARMACEUTICALS INC 3.3%

Value $4.539M Shares 850,000 Est. Cost $6.37 Unrealized -5.1%

INSM INSMED INC 2.8%

Value $3.881M Shares 220,000 Est. Cost $26.21 Unrealized -26.3%

— REATA PHARMACEUTICALS INC 2.6%

Value $3.613M Shares 45,000 Est. Cost $80.29 Unrealized —

VCYT VERACYTE INC 1.9%

Value $2.7M Shares 112,500 Est. Cost $10.93 Unrealized +143.4%

ARGX ARGENX SE 1.9%

Value $2.564M Shares 22,500 Est. Cost $78.55 Unrealized —

— KARYOPHARM THERAPEUTICS INC 1.6%

Value $2.285M Shares 237,500 Est. Cost $9.62 Unrealized —

IRIX IRIDEX CORP 1.6%

Value $2.167M Shares 1,171,300 Est. Cost $11.40 Unrealized -74.3%

— AMARIN CORP PLC 1.1%

Value $1.516M Shares 100,000 Est. Cost $15.16 Unrealized —

KURA KURA ONCOLOGY INC 1.0%

Value $1.441M Shares 95,000 Est. Cost $17.80 Unrealized 0.0%

— MIRATI THERAPEUTICS INC 1.0%

Value $1.324M Shares 17,000 Est. Cost $83.51 Unrealized —

— ZYMEWORKS INC 0.9%

Value $1.302M Shares 52,500 Est. Cost $24.80 Unrealized —

— RA PHARMACEUTICALS INC 0.9%

Value $1.301M Shares 55,000 Est. Cost $23.65 Unrealized —

— ASSEMBLY BIOSCIENCES INC 0.9%

Value $1.293M Shares 131,500 Est. Cost $16.58 Unrealized —

— MERUS N V 0.9%

Value $1.234M Shares 69,274 Est. Cost $17.81 Unrealized —

PTCT PTC THERAPEUTICS INC 0.9%

Value $1.218M Shares 36,000 Est. Cost $43.52 Unrealized 0.0%

FOLD AMICUS THERAPEUTICS INC 0.8%

Value $1.123M Shares 140,000 Est. Cost $12.69 Unrealized -14.5%

— APPLIED THERAPEUTICS INC 0.7%

Value $912K Shares 83,000 Est. Cost $10.99 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 0.2%

Value $290K Shares 25,000 Est. Cost $16.48 Unrealized -1.9%

— SUNESIS PHARMACEUTICALS INC 0.2%

Value $288K Shares 400,000 Est. Cost $0.72 Unrealized —

— CHEMBIO DIAGNOSTICS INC 0.2%

Value $255K Shares 41,667 Est. Cost $7.05 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	KADMON HLDGS INC	6,412,500	$16.16M	11.7%	$3.68	—	COM	48283N106
IOVA	IOVANCE BIOTHERAPEUTICS INC	727,500	$13.24M	9.6%	$7.92	+179.3%	COM	462260100
ARVN	ARVINAS INC	566,500	$12.21M	8.8%	$19.30	+27.2%	COM	04335A105
XBI	SPDR SERIES TRUST	150,000	$11.44M	8.3%	—	—	Put	78464A870
ARWR	ARROWHEAD PHARMACEUTICALS IN	387,500	$10.92M	7.9%	$20.04	+47.7%	COM	04280A100
AXSM	AXSOME THERAPEUTICS INC	522,500	$10.57M	7.6%	$20.96	+22.6%	COM	05464T104
MIST	MILESTONE PHARMACEUTICALS IN	369,500	$6.891M	5.0%	$20.57	-4.2%	COM	59935V107
XENE	XENON PHARMACEUTICALS INC	702,500	$6.33M	4.6%	$7.43	+27.2%	COM	98420N105
CRSP	CRISPR THERAPEUTICS AG	134,000	$5.493M	4.0%	$43.18	+10.7%	NAMEN AKT	H17182108
PTGX	PROTAGONIST THERAPEUTICS INC	418,500	$5.026M	3.6%	$9.94	+26.9%	COM	74366E102
—	BELLUS HEALTH INC NEW	785,000	$5.016M	3.6%	$6.39	—	COM NEW	07987C204
AUPH	AURINIA PHARMACEUTICALS INC	850,000	$4.539M	3.3%	$6.37	-5.1%	COM	05156V102
INSM	INSMED INC	220,000	$3.881M	2.8%	$26.21	-26.3%	COM PAR $.01	457669307
—	REATA PHARMACEUTICALS INC	45,000	$3.613M	2.6%	$80.29	—	CL A	75615P103
VCYT	VERACYTE INC	112,500	$2.7M	1.9%	$10.93	+143.4%	COM	92337F107
ARGX	ARGENX SE	22,500	$2.564M	1.9%	$78.55	—	SPONSORED ADR	04016X101
—	KARYOPHARM THERAPEUTICS INC	237,500	$2.285M	1.6%	$9.62	—	COM	48576U106
IRIX	IRIDEX CORP	1,171,300	$2.167M	1.6%	$11.40	-74.3%	COM	462684101
—	AMARIN CORP PLC	100,000	$1.516M	1.1%	$15.16	—	SPONS ADR NEW	023111206
KURA	KURA ONCOLOGY INC	95,000	$1.441M	1.0%	$17.80	0.0%	COM	50127T109
—	MIRATI THERAPEUTICS INC	17,000	$1.324M	1.0%	$83.51	—	COM	60468T105
—	ZYMEWORKS INC	52,500	$1.302M	0.9%	$24.80	—	COM	98985W102
—	RA PHARMACEUTICALS INC	55,000	$1.301M	0.9%	$23.65	—	COM	74933V108
—	ASSEMBLY BIOSCIENCES INC	131,500	$1.293M	0.9%	$16.58	—	COM	045396108
—	MERUS N V	69,274	$1.234M	0.9%	$17.81	—	COM	N5749R100
PTCT	PTC THERAPEUTICS INC	36,000	$1.218M	0.9%	$43.52	0.0%	COM	69366J200
FOLD	AMICUS THERAPEUTICS INC	140,000	$1.123M	0.8%	$12.69	-14.5%	COM	03152W109
—	APPLIED THERAPEUTICS INC	83,000	$912K	0.7%	$10.99	—	COM	03828A101
KALV	KALVISTA PHARMACEUTICALS INC	25,000	$290K	0.2%	$16.48	-1.9%	COM	483497103
—	SUNESIS PHARMACEUTICALS INC	400,000	$288K	0.2%	$0.72	—	COM	867328700
—	CHEMBIO DIAGNOSTICS INC	41,667	$255K	0.2%	$7.05	—	COM NEW	163572209